Table 2.
Comparison of Baseline Donor Characteristics Between Hepatitis C–Negative and Hepatitis C–Positive Donors After Propensity Matching
| Hepatitis C Negative (n=437) | Hepatitis C Positive (n=238) | P Value | |
|---|---|---|---|
| Age, y (IQR) | 32 (24–42) | 33 (27–38) | 0.42 |
| Female, n (%) | 136 (31.1) | 73 (30.7) | 0.90 |
| Race, n (%) | 0.13 | ||
| White | 352 (80.6) | 197 (82.8) | |
| Black | 50 (11.4) | 21 (8.8) | |
| Hispanic | 31 (7.1) | 16 (6.7) | |
| Asian | 3 (0.7) | 0 (0) | |
| Other | 1 (0.2) | 4 (1.7) | |
| Body mass index, kg/m2 (IQR) | 26 (23–31) | 26 (24–31) | 0.98 |
| Blood type, n (%) | 0.45 | ||
| A | 146 (33.4) | 78 (32.8) | |
| AB | 26 (6.0) | 11 (4.6) | |
| B | 64 (14.7) | 27 (11.3) | |
| O | 201 (46.0) | 122 (51.3) | |
| Cytomegalovirus positive | 231 (53.0) | 123 (51.9) | 0.79 |
| Mechanism of donor death, n (%) | <0.001 | ||
| Trauma | 106 (24.3) | 44 (18.5) | |
| Cerebrovascular | 66 (15.1) | 13 (5.5) | |
| Drug overdose | 91 (20.8) | 154 (64.7) | |
| Other | 174 (39.8) | 27 (11.3) | |
| Diabetes mellitus | 19 (4.4) | 8 (3.4) | 0.54 |
| Inotrope use | 157 (35.9) | 81 (34.0) | 0.62 |
| Terminal serum creatinine, mg/dL (IQR) | 1.00 (0.73–1.72) | 1.10 (0.80–1.77) | 0.13 |
| Left ventricular ejection fraction, % (IQR) | 60 (57–65) | 60 (56–65) | 0.43 |
IQR indicates interquartile range.